Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/11/2026 | Q4 | $80.8M | -- | -- | $0.50 | -- |
| 11/06/2025 | Q3 | $83.9M | $229.8M | -$0.27 | $0.46 | -$0.73 |
| 08/06/2025 | Q2 | $83.4M | $198.3M | $0.17 | $0.46 | -$0.29 |
| 05/08/2025 | Q1 | $73.8M | $203.4M | $1.77 | $0.40 | $1.37 |
| 02/12/2025 | Q4 | $73.5M | $201.3M | -$2.08 | $0.38 | -$2.46 |
| 11/06/2024 | Q3 | $73.8M | $198.6M | $1.39 | $0.38 | $1.01 |
| 08/07/2024 | Q2 | $71.3M | $177.4M | $0.41 | $0.35 | $0.06 |
| 05/09/2024 | Q1 | $72M | $193M | $1.36 | $0.48 | $0.88 |
| 02/14/2024 | Q4 | $78.9M | $191.8M | $0.16 | $0.50 | -$0.35 |
| 11/02/2023 | Q3 | -- | $202.4M | -$0.22 | -- | -- |
| 08/03/2023 | Q2 | -- | $172M | $0.23 | -- | -- |
| 05/04/2023 | Q1 | -- | $152.8M | $0.50 | -- | -- |
| 02/15/2023 | Q4 | -- | $144.9M | $1.02 | -- | -- |
| 11/03/2022 | Q3 | -- | $150.8M | -$2.65 | -- | -- |
| 08/04/2022 | Q2 | -- | $196.3M | -$2.29 | -- | -- |
| 05/05/2022 | Q1 | -- | $202.2M | -$3.56 | -- | -- |
| 02/17/2022 | Q4 | -- | $221.2M | -$0.01 | -- | -- |
| 11/03/2021 | Q3 | -- | $220.6M | $3.91 | -- | -- |
| 08/04/2021 | Q2 | -- | $260.2M | $1.80 | -- | -- |
| 05/05/2021 | Q1 | -- | $280.9M | $1.60 | -- | -- |
| 02/10/2021 | Q4 | -- | $235.8M | $1.68 | -- | -- |
| 11/04/2020 | Q3 | -- | $312.9M | $3.94 | -- | -- |
| 08/05/2020 | Q2 | -- | $272.3M | -$1.10 | -- | -- |
| 05/06/2020 | Q1 | -- | -$128.9M | -$6.24 | -- | -- |
| 02/12/2020 | Q4 | -- | $352.7M | $1.78 | -- | -- |
| 10/30/2019 | Q3 | -- | $163.4M | $1.40 | -- | -- |
| 07/31/2019 | Q2 | -- | $227.5M | $0.64 | -- | -- |
| 05/01/2019 | Q1 | -- | $243.7M | $1.61 | -- | -- |
| 02/13/2019 | Q4 | -- | $353M | -$1.88 | -- | -- |
| 10/31/2018 | Q3 | -- | $318.5M | $2.36 | -- | -- |
| 08/01/2018 | Q2 | -- | $307.2M | $1.74 | -- | -- |
| 05/03/2018 | Q1 | -- | $310.2M | $3.66 | -- | -- |
| 02/14/2018 | Q4 | -- | $304.4M | $1.56 | -- | -- |
| 11/02/2017 | Q3 | -- | $289M | $2.07 | -- | -- |
| 08/02/2017 | Q2 | -- | $265.6M | $1.68 | -- | -- |
| 05/01/2017 | Q1 | -- | $247.2M | $2.52 | -- | -- |
| 02/14/2017 | Q4 | -- | $286M | $3.48 | -- | -- |
| 11/01/2016 | Q3 | -- | $239.8M | $2.76 | -- | -- |
| 08/04/2016 | Q2 | -- | $157.9M | $1.17 | -- | -- |
| 05/02/2016 | Q1 | -- | $258.1M | $1.32 | -- | -- |
| 02/17/2016 | Q4 | -- | $233.9M | $1.80 | -- | -- |
Chimera Investment Corp. reported $229.8M worth of top line sales in its most recent quarter.
Chimera Investment Corp. announced earnings per share of -$0.27 which represents a miss of analyst forecast a $0.46 per share.
Chimera Investment Corp. reported $211.9M that represents $2.60 per share over the last quarter.
Chimera Investment Corp.'s earnings are forecast to grow from $1.10 per share to $1.49 per share next year representing an increase of 60.06%.
Chimera Investment Corp.'s next earnings date is February 11, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.